{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T16:51:23Z","timestamp":1789750283837,"version":"4.0.1"},"reference-count":43,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"52","license":[{"start":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T00:00:00Z","timestamp":1735257600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,12,27]]},"abstract":"<jats:p>\n                    This study investigates the differences between COVID-19 and past common forms of pneumonia and to determine if COVID-19 acts as a contributing factor in various cardiovascular diseases (CVDs). We retrieved large-sample genome-wide association study data from the Open GWAS database related to COVID-19, bacterial pneumonia (BP), viral pneumonia (VP), stable angina (SA), unstable angina (UA), heart failure (HF), ischemic heart disease (IHD), atrial fibrillation (AF), and myocardial infarction (MI). We selected single-nucleotide polymorphisms with strong correlations as instrumental variables (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u20055E-06), and set the threshold for the F-statistic to be over 10. Five statistical methods were used for analysis including inverse variance weighted, Mendelian randomization-Egger, weighted median, simple mode, and weighted mode, with inverse variance weighted as the primary method. We assessed the reliability of our results through heterogeneity, pleiotropy, and sensitivity testing; Our analysis probed the relationship between COVID-19, BP, VP, and 6 CVDs. COVID-19 infection was found to enhance the incidence of SA, UA, HF, and MI (SA: odds ratio [OR], 1.12; 95% confidence interval [CI], 1.04\u20131.20;\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.002; UA: OR, 1.14; 95% CI, 1.01\u20131.29;\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.041; HF: OR, 1.12; 95% CI, 1.03\u20131.23;\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.012; MI: OR, 1.11; 95% CI, 1.02\u20131.25;\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.032). There was no significant effect on the incidence of AF or IHD (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&gt;\u2005.05), and no pleiotropy or sensitivity issues were found in the results. In contrast, neither past common BP nor VP was found to contribute to the progression of these 6 CVDs (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&gt;\u2005.05). Unlike past common BP or VP, COVID-19 was found to increase the risks of SA, UA, HF, and MI, with no evidence supporting an increased risk for AF or IHD following COVID-19 infection.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000041015","type":"journal-article","created":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T21:00:49Z","timestamp":1735592449000},"page":"e41015","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Unlike common pneumonia, COVID-19 is a risk factor for multiple cardiovascular diseases: A two-sample Mendelian randomization study"],"prefix":"10.1097","volume":"103","author":[{"given":"Chengjia","family":"Li","sequence":"first","affiliation":[{"name":"Heilongjiang University of Chinese Medicine, Harbin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-5053-2306","authenticated-orcid":false,"given":"Huijun","family":"Chen","sequence":"additional","affiliation":[{"name":"Heilongjiang University of Chinese Medicine affiliated second hospital, Harbin, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260911","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/S0140-6736(21)01258-7","article-title":"Tracking development assistance for health and for COVID-19: a review of development assistance, government, out-of-pocket, and other private spending on health for 204 countries and territories, 1990-2050.","volume":"398","year":"2021","journal-title":"Lancet"},{"key":"R2-20260911","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0140-6736(20)32228-5","article-title":"Fragmented health systems in COVID-19: rectifying the misalignment between global health security and universal health coverage.","volume":"397","author":"Lal","year":"2021","journal-title":"Lancet"},{"key":"R3-20260911","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1038\/s41591-022-01840-0","article-title":"Long COVID after breakthrough SARS-CoV-2 infection.","volume":"28","author":"Al-Aly","year":"2022","journal-title":"Nat Med"},{"key":"R4-20260911","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/S0140-6736(22)01214-4","article-title":"Persistence of somatic symptoms after COVID-19 in the Netherlands: an observational cohort study.","volume":"400","author":"Ballering","year":"2022","journal-title":"Lancet"},{"key":"R5-20260911","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1038\/s41577-023-00904-7","article-title":"The immunology of long COVID.","volume":"23","author":"Altmann","year":"2023","journal-title":"Nat Rev Immunol"},{"key":"R6-20260911","doi-asserted-by":"crossref","first-page":"e015245","DOI":"10.1136\/bmjgh-2024-015245","article-title":"Long Covid: a global health issue - a prospective, cohort study set in four continents.","volume":"9","author":"Pazukhina","year":"2024","journal-title":"BMJ Glob Health"},{"key":"R7-20260911","doi-asserted-by":"crossref","first-page":"3135","DOI":"10.1038\/s41564-024-01838-z","article-title":"Post-acute sequelae of SARS-CoV-2 cardiovascular symptoms are associated with trace-level cytokines that affect cardiomyocyte function.","volume":"9","author":"Sinclair","year":"2024","journal-title":"Nat Microbiol"},{"key":"R8-20260911","doi-asserted-by":"crossref","first-page":"e34408","DOI":"10.7554\/eLife.34408","article-title":"The MR-base platform supports systematic causal inference across the human phenome.","volume":"7","author":"Hemani","year":"2018","journal-title":"Elife"},{"key":"R9-20260911","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s10654-015-0011-z","article-title":"Using published data in Mendelian randomization: a blueprint for efficient identification of causal risk factors.","volume":"30","author":"Burgess","year":"2015","journal-title":"Eur J Epidemiol"},{"key":"R10-20260911","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/gepi.21758","article-title":"Mendelian randomization analysis with multiple genetic variants using summarized data.","volume":"37","author":"Burgess","year":"2013","journal-title":"Genet Epidemiol"},{"key":"R11-20260911","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/ije\/dyv080","article-title":"Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression.","volume":"44","author":"Bowden","year":"2015","journal-title":"Int J Epidemiol"},{"key":"R12-20260911","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/gepi.21965","article-title":"Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator.","volume":"40","author":"Bowden","year":"2016","journal-title":"Genet Epidemiol"},{"key":"R13-20260911","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/ng.3538","article-title":"Integration of summary data from GWAS and eQTL studies predicts complex trait gene targets.","volume":"48","author":"Zhu","year":"2016","journal-title":"Nat Genet"},{"key":"R14-20260911","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1038\/s41467-018-03371-0","article-title":"Integrative analysis of omics summary data reveals putative mechanisms underlying complex traits.","volume":"9","author":"Wu","year":"2018","journal-title":"Nat Commun"},{"key":"R15-20260911","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1093\/ije\/dyx102","article-title":"Robust inference in summary data Mendelian randomization via the zero modal pleiotropy assumption.","volume":"46","author":"Hartwig","year":"2017","journal-title":"Int J Epidemiol"},{"key":"R16-20260911","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1556\/2060.2023.00256","article-title":"Beyond the acute illness: exploring long COVID and its impact on multiple organ systems.","volume":"110","author":"Bhattacharjee","year":"2023","journal-title":"Physiol Int"},{"key":"R17-20260911","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1086\/518849","article-title":"The association between pneumococcal pneumonia and acute cardiac events.","volume":"45","author":"Musher","year":"2007","journal-title":"Clin Infect Dis"},{"key":"R18-20260911","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1056\/NEJMoa1702090","article-title":"Acute myocardial infarction after laboratory-confirmed influenza infection.","volume":"378","author":"Kwong","year":"2018","journal-title":"N Engl J Med"},{"key":"R19-20260911","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1093\/qjmed\/hcy305","article-title":"Influenza virus and atherosclerosis.","volume":"112","author":"Peretz","year":"2019","journal-title":"QJM"},{"key":"R20-20260911","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1001\/jama.2014.18229","article-title":"Association between hospitalization for pneumonia and subsequent risk of cardiovascular disease.","volume":"313","author":"Corrales-Medina","year":"2015","journal-title":"JAMA"},{"key":"R21-20260911","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1001\/jamacardio.2020.1017","article-title":"Cardiovascular implications of fatal outcomes of patients with Coronavirus disease 2019 (COVID-19).","volume":"5","author":"Guo","year":"2020","journal-title":"JAMA Cardiol"},{"key":"R22-20260911","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.jacbts.2022.01.013","article-title":"Plasma proteomics of COVID-19-associated cardiovascular complications: implications for pathophysiology and therapeutics.","volume":"7","author":"Roh","year":"2022","journal-title":"JACC Basic Transl Sci"},{"key":"R23-20260911","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.jacc.2020.06.007","article-title":"Prevalence and impact of myocardial injury in patients hospitalized with COVID-19 infection.","volume":"76","author":"Lala","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"R24-20260911","first-page":"249","article-title":"Cardiovascular complications of COVID-19.","volume":"28","author":"Lo","year":"2022","journal-title":"Hong Kong Med J"},{"key":"R25-20260911","first-page":"478497","article-title":"Human cardiac organoids to model COVID-19 cytokine storm induced cardiac injuries.","volume":"01.31","author":"Arhontoulis","year":"2022","journal-title":"bioRxiv"},{"key":"R26-20260911","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1164\/rccm.202001-0179LE","article-title":"Single-cell RNA expression profiling of ACE2, the receptor of SARS-CoV-2.","volume":"202","author":"Zhao","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"R27-20260911","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor.","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"R28-20260911","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.cell.2020.04.026","article-title":"Imbalanced host response to SARS-CoV-2 drives development of COVID-19.","volume":"181","author":"Blanco-Melo","year":"2020","journal-title":"Cell"},{"key":"R29-20260911","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.18632\/aging.202375","article-title":"Lung adenocarcinoma patients have higher risk of SARS-CoV-2 infection.","volume":"13","author":"Chen","year":"2021","journal-title":"Aging (Albany NY)"},{"key":"R30-20260911","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"R31-20260911","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s11684-020-0754-0","article-title":"Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection.","volume":"14","author":"Zou","year":"2020","journal-title":"Front Med"},{"key":"R32-20260911","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1093\/nsr\/nwaa123","article-title":"Autopsy of COVID-19 patients in China.","volume":"7","author":"Bian","year":"2020","journal-title":"Natl Sci Rev"},{"key":"R33-20260911","first-page":"265561","article-title":"SARS-CoV-2 infection of human iPSC-derived cardiac cells predicts novel cytopathic features in hearts of COVID-19 patients.","volume":"08.25","author":"Perez-Bermejo","year":"2020","journal-title":"bioRxiv"},{"key":"R34-20260911","doi-asserted-by":"crossref","first-page":"100052","DOI":"10.1016\/j.xcrm.2020.100052","article-title":"Human iPSC-derived cardiomyocytes are susceptible to SARS-CoV-2 infection.","volume":"1","author":"Sharma","year":"2020","journal-title":"Cell Rep Med"},{"key":"R35-20260911","doi-asserted-by":"crossref","first-page":"5589089","DOI":"10.1155\/2022\/5589089","article-title":"Oxidative stress-related mechanisms in SARS-CoV-2 infections.","volume":"2022","author":"Wieczfinska","year":"2022","journal-title":"Oxid Med Cell Longev"},{"key":"R36-20260911","doi-asserted-by":"crossref","first-page":"799558","DOI":"10.3389\/fimmu.2021.799558","article-title":"Persistent oxidative stress and inflammasome activation in CD14(high)CD16(-) monocytes from COVID-19 patients.","volume":"12","author":"Lage","year":"2021","journal-title":"Front Immunol"},{"key":"R37-20260911","doi-asserted-by":"crossref","first-page":"eabq1533","DOI":"10.1126\/scitranslmed.abq1533","article-title":"Core mitochondrial genes are down-regulated during SARS-CoV-2 infection of rodent and human hosts.","volume":"15","author":"Guarnieri","year":"2023","journal-title":"Sci Transl Med"},{"key":"R38-20260911","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.jiph.2023.03.015","article-title":"The molecular mechanism of cardiac injury in SARS-CoV-2 infection: focus on mitochondrial dysfunction.","volume":"16","author":"Shen","year":"2023","journal-title":"J Infect Public Health"},{"key":"R39-20260911","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41541-022-00526-5","article-title":"Association between BNT162b2 vaccination and reported incidence of post-COVID-19 symptoms: cross-sectional study 2020-21, Israel.","volume":"7","author":"Kuodi","year":"2022","journal-title":"npj Vaccines"},{"key":"R40-20260911","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.bbi.2022.04.013","article-title":"Six-month sequelae of post-vaccination SARS-CoV-2 infection: a retrospective cohort study of 10,024 breakthrough infections.","volume":"103","author":"Taquet","year":"2022","journal-title":"Brain Behav Immun"},{"key":"R41-20260911","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S1473-3099(21)00460-6","article-title":"Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID symptom study app: a prospective, community-based, nested, case-control study.","volume":"22","author":"Antonelli","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"R42-20260911","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.cell.2022.01.014","article-title":"Multiple early factors anticipate post-acute COVID-19 sequelae.","volume":"185","author":"Su","year":"2022","journal-title":"Cell"},{"key":"R43-20260911","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/d41586-023-01371-9","article-title":"Are repeat COVID infections dangerous? What the science says.","volume":"616","author":"Willyard","year":"2023","journal-title":"Nature"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000041015","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T16:04:37Z","timestamp":1789142677000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000041015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,27]]},"references-count":43,"journal-issue":{"issue":"52","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000041015","relation":{},"ISSN":["1536-5964","0025-7974"],"issn-type":[{"value":"1536-5964","type":"electronic"},{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12,27]]}}}